Sarah K Ballou (Sarah Ballou, S Ballou)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Randomized Controlled Trial

Irritable Bowel Syndrome

Ejection Fraction

Top Venues

Neurogastroenterology and motility

Alimentary pharmacology & therapeutics

Clinical psychology in Europe

The American journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah K Ballou, Dipesh Harshvadan Vasant, Livia Guadagnoli, Bonney Reed, Giuseppe Chiarioni, Liesbeth Ten Cate, Laurie Keefer, Sarah W Kinsinger
A primer for the gastroenterology provider on psychosocial assessment of patients with disorders of gut-brain interaction. Neurogastroenterology and motility (2024)
Lea Balthasar, Anne-Kathrin Bräscher, Ted J Kaptchuk, Sarah K Ballou, Tobias Kube
Development and Psychometric Evaluation of the Hope in Medicine Scale. Clinical psychology in Europe 6 (1) (2024)
Sarah K Ballou, Tobias Kube
Open-label placebo is an evidence-based treatment option for many chronic conditions. Pain 165 (2) (2024)
Rafla Hassan, Prashant Singh, Sarah K Ballou, Vikram Rangan, Johanna Iturrino, Jesse Katon, Anthony Lembo, Judy Nee
Prevalence and determinants of postprandial diarrhea in a tertiary care center. Neurogastroenterology and motility 36 (7) (2024)
Sarah K Ballou, Dipesh Harshvadan Vasant, Livia Guadagnoli, Bonney Reed, Giuseppe Chiarioni, Liesbeth Ten Cate, Laurie Keefer, Sarah W Kinsinger
A primer for the gastroenterology provider on psychosocial assessment of patients with disorders of gut-brain interaction. Neurogastroenterology and motility (2024)
Rafla Hassan, Prashant Singh, Sarah K Ballou, Vikram Rangan, Johanna Iturrino, Jesse Katon, Anthony Lembo, Judy Nee
Prevalence and determinants of postprandial diarrhea in a tertiary care center. Neurogastroenterology and motility (2024)
Rafla Hassan, Prashant Singh, Sarah K Ballou, Vikram Rangan, Johanna Iturrino, Jesse Katon, Anthony Lembo, Judy Nee
Prevalence and determinants of postprandial diarrhea in a tertiary care center. Neurogastroenterology and motility 36 (7) (2024)
Lea Balthasar, Anne-Kathrin Bräscher, Ted J Kaptchuk, Sarah K Ballou, Tobias Kube
Development and Psychometric Evaluation of the Hope in Medicine Scale. Clinical psychology in Europe 6 (1) (2024)
Sarah K Ballou, Vikram Rangan, Andrew Eidelberg, Samantha Proctor, Nicole McHenry, Judy Nee, Johanna Iturrino, Anthony Lembo, Prashant Singh
What is unspecified functional bowel disorder? A commonly seen, rarely recognized, and poorly understood diagnosis. The American journal of gastroenterology (2023)
Giulio Ongaro, Sarah K Ballou, Tobias Kube, Julia Haas, Ted J Kaptchuk
Doctors Speak: A Qualitative Study of Physicians' Prescribing of Antidepressants in Functional Bowel Disorders. Culture, medicine and psychiatry (2022)
Sarah K Ballou, Anthony J Lembo
Editorial: symptom improvement does not equal satisfaction with treatment for constipation. Alimentary pharmacology & therapeutics 51 (9) (2020)
Sarah K Ballou, Prashant Singh, Vikram Rangan, Johanna Iturrino, Judy Nee, Anthony J Lembo
Obesity is associated with significantly increased risk for diarrhoea after controlling for demographic, dietary and medical factors: a cross-sectional analysis of the 2009-2010 National Health and Nutrition Examination Survey. Alimentary pharmacology & therapeutics 50 (9) (2019)
Sarah K Ballou, William Hirsch, Prashant Singh, V Rangan, J Nee, J Iturrino, T Sommers, J Zubiago, N Sengupta, A Bollom, M Jones, A C Moss, S N Flier, A S Cheifetz, A Lembo
Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014. Alimentary pharmacology & therapeutics 47 (7) (2018)
Sarah K Ballou, A Lembo
Editorial: latent class analysis to improve confidence in the diagnosis of IBS. Alimentary pharmacology & therapeutics 45 (9) (2017)
Sarah K Ballou, Ted J Kaptchuk, William Hirsch, Judy Nee, Johanna Iturrino, Kathryn T Hall, John M Kelley, Vivian Cheng, Irving Kirsch, Eric Jacobson, Lisa Conboy, Anthony Lembo, Roger B Davis
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials 18 (1) (2017)